Kilitch Drugs (India) Limited (IN:KILITCH)
:KILITCH
Want to see IN:KILITCH full AI Analyst Report?
Total Valuation
Kilitch Drugs (India) Limited has a market cap or net worth of ₹6.39B. The enterprise value is ₹7.09B.
Market Cap₹6.39B
Enterprise Value₹7.09B
Share Statistics
Kilitch Drugs (India) Limited has 34,961,563 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,961,563
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kilitch Drugs (India) Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 6.87%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)6.87%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee14.02M
Profits Per Employee1.80M
Employee Count168
Asset Turnover0.51
Inventory Turnover12.50
Valuation Ratios
The current PE Ratio of Kilitch Drugs (India) Limited is 7.3. Kilitch Drugs (India) Limited’s PEG ratio is 1.44.
PE Ratio7.3
PS Ratio1.79
PB Ratio1.51
Price to Fair Value1.51
Price to FCF-5.23
Price to Operating Cash Flow-93.42
PEG Ratio1.44
Income Statement
In the last 12 months, Kilitch Drugs (India) Limited had revenue of 2.35B and earned 301.66M in profits. Earnings per share was 8.91.
Revenue2.35B
Gross Profit914.13M
Operating Income329.77M
Pretax Income386.54M
Net Income301.66M
EBITDA366.00M
Earnings Per Share (EPS)8.91
Cash Flow
In the last 12 months, operating cash flow was -66.20M and capital expenditures -515.03M, giving a free cash flow of -581.23M billion.
Operating Cash Flow-66.20M
Free Cash Flow-581.23M
Free Cash Flow per Share-16.62
Dividends & Yields
Kilitch Drugs (India) Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of ―
Dividend Per Share₹0.5
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change-24.42%
50-Day Moving Average152.07
200-Day Moving Average172.72
Relative Strength Index (RSI)70.49
Average Volume (3m)2.19K
Important Dates
Kilitch Drugs (India) Limited upcoming earnings date is Aug 7, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Kilitch Drugs (India) Limited as a current ratio of 1.83, with Debt / Equity ratio of 31.72%
Current Ratio1.83
Quick Ratio1.73
Debt to Market Cap0.21
Net Debt to EBITDA1.97
Interest Coverage Ratio5.93
Taxes
In the past 12 months, Kilitch Drugs (India) Limited has paid 91.54M in taxes.
Income Tax91.54M
Effective Tax Rate0.24
Enterprise Valuation
Kilitch Drugs (India) Limited EV to EBITDA ratio is 13.48, with an EV/FCF ratio of -6.12.
EV to Sales2.09
EV to EBITDA13.48
EV to Free Cash Flow-6.12
EV to Operating Cash Flow26.04
Balance Sheet
Kilitch Drugs (India) Limited has ₹870.13M in cash and marketable securities with ₹836.13M in debt, giving a net cash position of ₹34.01M billion.
Cash & Marketable Securities₹870.13M
Total Debt₹836.13M
Net Cash₹34.01M
Net Cash Per Share₹0.97
Tangible Book Value Per Share₹76.47
Margins
Gross margin is 40.04%, with operating margin of 14.00%, and net profit margin of 12.81%.
Gross Margin40.04%
Operating Margin14.00%
Pretax Margin16.42%
Net Profit Margin12.81%
EBITDA Margin15.54%
EBIT Margin14.00%
Analyst Forecast
The average price target for Kilitch Drugs (India) Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.74%
EPS Growth Forecast11.32%